Etienne Guenou
Biographic Data
| ID | 7013541 |
|---|---|
| NAME | Etienne Guenou |
| GIVEN NAMES | Etienne |
| FAMILY NAME | Guenou |
| SIGNATURE | GUENOU E |
| AFFILIATIONS | University of Buea |
| ORCID | 0000-0002-8027-7311 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Serological responses to killed oral cholera vaccine (OCV) when given 4 years after initial receipt of OCV in Cameroon
Oral cholera vaccination (OCV) is one of strategies to help control cholera with two doses recommended as initial vaccination and booster doses recommended 3–5 years later to prevent future outbreaks. There is no actual recommendation on the number of doses required during booster vaccination. An OCV campaign conducted in Mogode-Cameroon provided an opportunity to determine if revaccination four years after would induce a booster response. 350 pe…
Continued T12 transmission and shared antibiotic resistance during 2018–2023 Vibrio cholerae outbreaks in Cameroon
Seventh pandemic Vibrio cholerae was first identified in Cameroon in 1971, causing several sporadic disease clusters with few cases. More recent years have seen larger cholera outbreaks, but the mechanism behind these periodic outbreaks is poorly understood, and it is unclear the degree to which antibiotic resistant strains contribute to disease burden and spread. We used whole genome sequencing to characterize 13 V. cholerae isolates from the 20…
An innovative approach in monitoring oral cholera vaccination campaign
It is feasible to plan and implement coverage survey after first round OCV campaign and use its results for the better planning of the second round. For the present study, this is associated to the improvement of OCV coverage in the second-round vaccination. If this is persistent in other contexts, it may apply to improve coverage of any health campaign that is organized in more than one round
No prominent works on this page.
An innovative approach in monitoring oral cholera vaccination campaign
It is feasible to plan and implement coverage survey after first round OCV campaign and use its results for the better planning of the second round. For the present study, this is associated to the improvement of OCV coverage in the second-round vaccination. If this is persistent in other contexts, it may apply to improve coverage of any health campaign that is organized in more than one round
Continued T12 transmission and shared antibiotic resistance during 2018–2023 Vibrio cholerae outbreaks in Cameroon
Seventh pandemic Vibrio cholerae was first identified in Cameroon in 1971, causing several sporadic disease clusters with few cases. More recent years have seen larger cholera outbreaks, but the mechanism behind these periodic outbreaks is poorly understood, and it is unclear the degree to which antibiotic resistant strains contribute to disease burden and spread. We used whole genome sequencing to characterize 13 V. cholerae isolates from the 20…
Serological responses to killed oral cholera vaccine (OCV) when given 4 years after initial receipt of OCV in Cameroon
Oral cholera vaccination (OCV) is one of strategies to help control cholera with two doses recommended as initial vaccination and booster doses recommended 3–5 years later to prevent future outbreaks. There is no actual recommendation on the number of doses required during booster vaccination. An OCV campaign conducted in Mogode-Cameroon provided an opportunity to determine if revaccination four years after would induce a booster response. 350 pe…
Vibrio bacteria research studies (3 works) · Cholera (2 works) · Cholera vaccine (2 works) · Medicine (2 works) · Vaccination (2 works) · Antibiotic resistance (1 works) · Antibiotic Resistance in Bacteria (1 works) · Antibiotics (1 works) · Bacillus and Francisella bacterial research (1 works) · Bacteria (1 works)